Multicontext Approach for Cognitive Function in Parkinson Disease

Recruiting N/A Interventional Study
PARKINSON DISEASE (Disorder)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
114 (estimated)
Sponsor
Washington University School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunately, existing cognitive interventions for PD, which focus on restoring deficient cognitive skills through cognitive trai…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Males and females over age 50 who meet criteria for typical idiopathic PD. 2. Hoehn \& Yahr stage I-III. 3. Have subjective cognitive decline (SCD) as defined by a positive answer to either question: * Do you feel like your thinking skills or memory are becoming worse or …
Contacts

Tasha D Doty, MA

785-865-8943

tdoty@wustl.edu

CONTACT

Erin Foster, PhD

314-286-1638

erfoster@wustl.edu

CONTACT